BRANFORD, Conn., May 25 /PRNewswire-FirstCall/ -- CuraGen Corporation announced today that Dr. Frank M. Armstrong, President and Chief Executive Officer, will present at the 2006 Bear Stearns Biotech Boston Confab on Wednesday, May 31, 2006, at 12:20 p.m. Eastern time. The conference is being hosted at the Boston Marriott Copley Place in Boston, MA.
Access to a live webcast of the presentation will be available at http://www.curagen.com. A replay of the webcast will be available three hours after the presentation and archived for 30 days thereafter.
About CuraGen
CuraGen Corporation is a biopharmaceutical company developing diverse approaches, including novel protein, antibody, and small molecule therapeutics, that aim to offer hope for patients with cancer, inflammatory diseases, and diabetes. CuraGen's strategic alliances have resulted in a deep pipeline of potential therapeutics that is being developed by the Company's experienced research and development teams. By leveraging the drug development strengths cultivated over the years, CuraGen expects to make a difference in the lives of patients by bringing forward promising therapeutics that address unmet medical needs. CuraGen is headquartered in Branford, Connecticut. For additional information please visit http://www.curagen.com.
CuraGen Contact: Glenn Schulman, Pharm.D. Assistant Director of Investor Relations gschulman@curagen.com (888) 436-6642
CuraGen CorporationCONTACT: Glenn Schulman, Pharm.D., Assistant Director of InvestorRelations of CuraGen, +1-888-436-6642, gschulman@curagen.com
Web site: http://www.curagen.com//
